Alyeska Investment Group
BHVN icon

Alyeska Investment Group’s Biohaven BHVN Stock Holding History

Alyeska Investment Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$3M – 594
2025
Q3 		$3M Buy
+200,000
New +$2.91M 0.01% 491
2025
Q2 		– Sell
-106,351
Closed -$2.56M – 565
2025
Q1 		$2.56M Hold
106,351
– – 0.01% 406
2024
Q4 		$3.97M Buy
106,351
+60,000
+129% +$2.8M 0.01% 413
2024
Q3 		$2.32M Hold
46,351
– – 0.01% 409
2024
Q2 		$1.61M Buy
+46,351
New +$1.83M 0.01% 429
2023
Q2 		– Sell
-250,000
Closed -$3.42M – 550
2023
Q1 		$3.42M Buy
250,000
+50,000
+25% +$796K 0.03% 324
2022
Q4 		$2.78M Buy
+200,000
New +$2.82M 0.03% 300

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group's BHVN Position: Q4 2025 in Review

Alyeska Investment Group sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 200,000 shares — an estimated $3M sold.

Alyeska Investment Group first reported a position in BHVN in Q4 2022 and held it in 7 quarters. The position peaked at $3.97M in Q4 2024. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Alyeska Investment Group reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 200,000 Biohaven shares in Q4 2025, an estimated $3M.
  • Alyeska Investment Group first reported a position in Biohaven in Q4 2022 and held it in 7 quarters.
  • Alyeska Investment Group's Biohaven position peaked at $3.97M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.